McDermott Will & Schulte has advised Swedish Orphan Biovitrum AB (Sobi), and Wilson Sonsini Goodrich & Rosati has advised Arthrosi Therapeutics on patent matters. Swedish Orphan...
Sobi to Acquire Arthrosi Therapeutics in $1.5 Billion Deal
Solve Therapeutics Secures $120 Million Funding to Advance ADC Drug Development
Wilson Sonsini Goodrich & Rosati has advised Solve Therapeutics. Solve Therapeutics, a clinical-stage biotechnology company, has secured $120 million in an oversubscribed and upsized financing round...
Imbria Pharmaceuticals Secures an Upsized Series B Financing
Wilson Sonsini Goodrich & Rosati has advised AXA IM Alts. Imbria Pharmaceuticals, a clinical-stage company advancing therapies for cardiovascular diseases, has announced an upsized Series B...
Novartis Acquires Avidity Biosciences in USD 12 Billion Transaction and Completes USD 11 Billion Financing
Covington and Homburger have advised Novartis. Kirkland & Ellis and Wilson Sonsini Goodrich & Rosati have advised Avidity Biosciences. Linklaters has advised a global underwriting syndicate....
Elevara Medicines Closes $70 Million Series A Financing
Goodwin Procter has advised Elevara Medicines, and Wilson Sonsini Goodrich & Rosati advised the company on IP matters. Elevara Medicines, a clinical-stage biotechnology company focused on...
ARS Pharmaceuticals Secures Favorable European Patent Office Decision on neffy® Nasal Spray Patent
Wilson Sonsini has advised ARS Pharmaceuticals. ARS Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, has announced that the European Patent Office (EPO) Opposition Division has upheld the...
Veradermics Launches Oversubscribed $150 Million Series C Financing Round
Wilson Sonsini Goodrich & Rosati advised lead investor SR One on the transaction. Veradermics, a dermatologist-founded, late clinical-stage biopharmaceutical company developing therapeutics for common dermatologic conditions,...
Expedition Therapeutics Closes $165 Million Series A Financing for COPD Therapy
Wilson Sonsini Goodrich & Rosati has advised Sofinnova Investments, Novo Holdings, and Forbion. Expedition Therapeutics, a biotechnology company specializing in therapies for novel inflammatory and respiratory...
ARS Pharmaceuticals Secures $250 Million Loan Facility to Expand Commercialization of neffy Nasal Spray
Wilson Sonsini Goodrich & Rosati has advised ARS Pharmaceuticals on patent matters related to the transaction. ARS Pharmaceuticals, Inc. has entered into a senior secured term...
Avidity Biosciences Prices $600 Million Upsized Public Offering of Common Stock
Wilson Sonsini Goodrich & Rosati along with Latham & Walkins have advised Avidity Biosciences. Avidity Biosciences, Inc., a biopharmaceutical company listed on Nasdaq under the symbol...
Enlaza and Vertex Pharmaceuticals Enter Multi-Target Drug Discovery Collaboration
Cooley and Wilson Sonsini Goodrich & Rosati have advised Enlaza Therapeutics, and Covington has advised Vertex Pharmaceuticals. Enlaza Therapeutics has entered into a multi-target drug discovery...
LENZ Therapeutics Secures FDA Approval for VIZZ in Presbyopia Treatment
Wilson Sonsini Goodrich & Rosati has advised LENZ Therapeutics on the transaction. LENZ Therapeutics announced that the U.S. Food and Drug Administration has approved VIZZ (aceclidine...